EUVIMEDEUVIMED entdecken
Open Access

Risk Factors for the Diagnosis of Progressive Supranuclear Palsy in the UK Biobank

Charlie Weige Zhao iD, Marian Dale iD, Alexander Pantelyat iD, Maria Carmela Tartaglia, Ruth B Schneider, David G Coughlin, Federico Rodriguez-Porcel iD, Zbigniew Wszolek iD, Tao Xie, Lawrence I Golbe, James B Rowe iD, Anne-Marie Wills iD

Movement Disorders · 2026-07 · 41 (7) · 1727-1739

DOI: 10.1002/mds.70287 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, online erschienen am 24.03.2026. Verfasst von Charlie Weige Zhao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Massachusetts General Brigham, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Supranuclear Palsy, Progressive. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Dolce family fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Progressive supranuclear palsy (PSP) is a tauopathy for which there is limited understanding of epidemiological risk factors.

Objective

The objective of this study was to identify premorbid nonmedical and medical risk factors for PSP diagnosis in a large prospective population‐based cohort.

Methods

We performed a matched nested case–control study using the UK Biobank (UKB) cohort consisting of >500,000 adults aged 37 to 73 years. PSP diagnoses were identified from 2007 to censor date (August 2025) and matched 1:10 by age and sex to control subjects without parkinsonism or dementia diagnoses. We derived risk factors using an iterative logistic regression approach.

Results

There were 240 incident PSP diagnoses in the UKB. In the fully adjusted model, premorbid depression (odds ratio [OR], 3.22; 95% confidence interval [CI], 2.30–4.50; P < 0.001), delirium (OR, 6.76; 95% CI, 4.08–11.19; P < 0.001), and functional gastrointestinal disorders (OR, 1.91; 95% CI, 1.39–2.63; P < 0.001) were associated with increased risk. Heavy alcohol consumption was associated with higher risk compared with moderate consumption (OR, 1.65; 95% CI: 1.21–2.26; P = 0.0017). Body mass index (BMI) and alcohol consumption had nonlinear risk profiles. Cancer diagnosis was inversely associated with PSP (OR, 0.56; 95% CI, 0.40–0.79; P < 0.001). Depression and delirium diagnoses remained significant 5 to 10 years before diagnosis.

Conclusions

In this large prospective cohort, PSP was associated with premorbid lifestyle practices and neuropsychiatric diagnoses years before diagnosis. This suggests a long premotor phase and highlights opportunities for earlier diagnosis and further mechanistic investigation. The inverse association with cancer mirrors the relationship seen in other neurodegenerative conditions and may point toward shared mechanisms. © 2026 International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Supranuclear Palsy, ProgressiveHumansMaleFemaleRisk FactorsUnited KingdomMiddle AgedCase-Control StudiesAgedAdultProspective StudiesBiological Specimen BanksUK BiobankCohort Studies

Stichwörter der Autor:innen

atypical parkinsonismcase control studyepidemiologyprogressive supranuclear palsyrisk factors

Autor:innen und Institutionen

  • Department of Neurology, Massachusetts General Brigham, Boston, Massachusetts, USA.
  • Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Neurology, Oregon Health and Science University, Portland, Oregon, USA.
  • Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada.
  • Memory Cinic, University Health Network, Toronto, Ontario, Canada.

ORCID-Profile: Charlie Weige Zhao, Marian Dale, Alexander Pantelyat, Federico Rodriguez-Porcel, Zbigniew Wszolek, James B Rowe, Anne-Marie Wills

Förderung

  • Dolce family fund

Zitieren

APA

Zhao, C. W., Dale, M., Pantelyat, A., Tartaglia, M. C., Schneider, R. B., Coughlin, D. G., Rodriguez-Porcel, F., Wszolek, Z., Xie, T., Golbe, L. I., Rowe, J. B., & Wills, A. M. (2026). Risk Factors for the Diagnosis of Progressive Supranuclear Palsy in the UK Biobank. Movement Disorders, 41(7), 1727-1739. https://doi.org/10.1002/mds.70287

Vancouver

Zhao CW, Dale M, Pantelyat A, Tartaglia MC, Schneider RB, Coughlin DG, et al. Risk Factors for the Diagnosis of Progressive Supranuclear Palsy in the UK Biobank. Movement Disorders. 2026;41(7):1727-1739. doi:10.1002/mds.70287

BibTeX
@article{Zhao2026,
  author = {Zhao, Charlie Weige and Dale, Marian and Pantelyat, Alexander and Tartaglia, Maria Carmela and Schneider, Ruth B and Coughlin, David G and Rodriguez-Porcel, Federico and Wszolek, Zbigniew and Xie, Tao and Golbe, Lawrence I and Rowe, James B and Wills, Anne-Marie},
  title = {Risk Factors for the Diagnosis of Progressive Supranuclear Palsy in the UK Biobank},
  journal = {Movement Disorders},
  year = {2026},
  volume = {41},
  number = {7},
  pages = {1727--1739},
  doi = {10.1002/mds.70287}
}
Kostenlos starten →